Quantifying axonal loss after optic neuritis with optical coherence tomography

Annals of Neurology

Volumn 59, Issue 6, 2006, Pages 963-969

  Costello, Fiona ^a,e   Coupland, Stuart ^b   Hodge, William ^b   Lorello, Gianni R ^b   Koroluk, Jeannie ^b   Pan, Y Irene ^c   Freedman, Mark S ^a   Zackon, David H ^b   Kardon, Randy H ^d  

^a Division of Neurology   (Canada)

^b Department of Ophthalmology ^*  (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISEASE MARKER; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THICKNESS; VISION; VISUAL DISORDER;

ADOLESCENT; ADULT; AXONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; OPTIC NEURITIS; PROGNOSIS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISION TESTS; VISUAL FIELDS;

EID: 33744826785     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20851     Document Type: Article

References (36)

1. Soderstrom M, Ya-Ping J, Hillert J, Link H. Optic neuritis prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 1998;50:708-714.
2. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4:281-288.
3. Soderstrom M. Optic neuritis and multiple sclerosis. Acta Ophthalmol Scand 2001;79:223-227.
4. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002;360:1953-1962.
5. Cleary PA, Beck RW, Bourque LB, et al. Visual symptoms after optic neuritis results from the optic neuritis treatment trial. J Neuroophthalmol 1997;17:18-28.
6. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181.
7. Baumal CR. Clinical applications of optical coherence tomography. Curr Opin Ophthalmol 1999;10:182-188.
8. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 2004;45:1716-1724.
9. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography: a pilot study. Arch Ophthalmol 1995;113:586-596.
10. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999;40:2520-2527.
11. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391.
12. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-332.
13. International Perimetric Society. 1990 perimetry standards. Available at: http://webeye.ophth.uiowa.edu/ips/GEN-INFO/ standards/IPS90.HTM. Accessed: Feb 21, 2006.
14. Ferris FL III, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94:91-96.
15. Quigley HA, Addicks EM. Quantitative studies of retinal nerve fiber layer defects. Arch Ophthalmol 1982;100:807-814.
16. Kupfer C. Retinal ganglion cell degeneration following chiasmal lesion in man. Arch Ophthalmol 1963;70:256-260.
17. Trobe JD, Beck RW, Moke PS, Cleary PA. Contrast sensitivity and other vision tests in the Optic Neuritis Treatment Trial. Am J Ophthalmol 1996;121:547-553.
18. Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992;326:581-588.
19. Optic Neuritis Study Group. The clinical profile of optic neuritis experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;109:1673-1678.
20. Beck RW, Cleary PA, Optic Neuritis Study Group. Optic Neuritis Treatment Trial one year follow-up results. Arch Ophthalmol 1993;111:773-775.
21. Keltner JL, Johnson CA, Spurr JO, Beck RW. Comparison of central and peripheral visual field properties in the Optic Neuritis Treatment Trial. Am J Ophthalmol 1999;128:543-553.
22. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989;107:453-464.
23. Kanamori A, Nakamura M, Escano MF, et al. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 2003;135:513-520.
24. Pieroth L, Schuman J, Hertzmark E, et al. Evaluation of focal defects of the nerve fiber layer using optical coherence tomography. Ophthalmology 1999;106:570-579.
25. Wollstein G, Schuman J, Price L, et al. Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields. Am J Ophthalmol 2004;138:218-225.
26. Macfayden DJ, Drance SM, Douglas GR, et al. The retinal nerve fiber layer, neuroretinal rim area, and visual evoked potential in MS. Neurology 1988;38:1353-1358.
27. Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994;14:445-451.
28. Steel DHW, Waldock A. Measurements of the retinal nerve fiber layer with scanning laser polarimetry in patients with previous demyelinating optic neuritis. J Neurol Neurosurg Psychiatry 1998;64:505-509.
29. Frisen L, Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Arch Ophthalmol 1974;92:91-97.
30. Elbol P, Work K. Retinal nerve fiber layer in multiple sclerosis. Acta Ophthalmol 1990;68:481-486.
31. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
32. Hood DC, Odel JG, Zhang X. Tracking the recovery of local optic nerve function after optic neuritis: a multifocal VEP study. Invest Ophthalmol Vis Sci 2000;41:4032-4038.
33. Simon JH, McDonald WI. Assessment of optic nerve damage in multiple sclerosis using magnetic resonance imaging. J Neurol Sci 2000;172:523-526.
34. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol 2005;4:341-348.
35. Hickman SJ, Toosy AT, Jones SJ, et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004;127:2498-2505.
36. Poser CM, Pary DW, Sheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.